See more : Pop Mart International Group Limited (9992.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Waters Corporation (WAT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Waters Corporation, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
You may be interested
- Keppel Pacific Oak US REIT (CMOU.SI) Income Statement Analysis – Financial Results
- China Longyuan Power Group Corporation Limited (0916.HK) Income Statement Analysis – Financial Results
- China World Trade Center Co., Ltd. (600007.SS) Income Statement Analysis – Financial Results
- Hawthorn Bancshares, Inc. (HWBK) Income Statement Analysis – Financial Results
- Advanced Lithium Electrochemistry (Cayman) Co., Ltd. (5227.TWO) Income Statement Analysis – Financial Results
Waters Corporation (WAT)
About Waters Corporation
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.96B | 2.97B | 2.79B | 2.37B | 2.41B | 2.42B | 2.31B | 2.17B | 2.04B | 1.99B | 1.90B | 1.84B | 1.85B | 1.64B | 1.50B | 1.58B | 1.47B | 1.28B | 1.16B | 1.10B | 958.21M | 889.97M | 859.21M | 795.07M | 704.40M | 618.80M | 465.50M | 391.10M | 333.00M |
| Cost of Revenue | 1.20B | 1.25B | 1.16B | 1.01B | 1.01B | 992.56M | 947.07M | 891.45M | 842.67M | 824.91M | 783.46M | 737.61M | 730.49M | 653.30M | 594.88M | 661.27M | 631.12M | 536.19M | 478.36M | 454.81M | 397.85M | 373.47M | 311.23M | 265.90M | 235.60M | 213.40M | 158.70M | 133.60M | 109.70M |
| Gross Profit | 1.76B | 1.72B | 1.63B | 1.36B | 1.40B | 1.43B | 1.36B | 1.28B | 1.20B | 1.16B | 1.12B | 1.11B | 1.12B | 990.07M | 903.82M | 913.86M | 841.93M | 744.04M | 679.88M | 649.73M | 560.36M | 516.50M | 547.98M | 529.17M | 468.80M | 405.40M | 306.80M | 257.50M | 223.30M |
| Gross Profit Ratio | 59.57% | 58.00% | 58.49% | 57.44% | 58.00% | 58.98% | 58.99% | 58.87% | 58.74% | 58.53% | 58.86% | 59.99% | 60.54% | 60.25% | 60.31% | 58.02% | 57.16% | 58.12% | 58.70% | 58.82% | 58.48% | 58.04% | 63.78% | 66.56% | 66.55% | 65.51% | 65.91% | 65.84% | 67.06% |
| Research & Development | 174.95M | 176.19M | 168.36M | 140.78M | 142.96M | 143.40M | 132.59M | 125.19M | 118.55M | 107.73M | 100.54M | 96.00M | 92.35M | 84.27M | 77.15M | 81.59M | 80.65M | 77.31M | 66.91M | 65.24M | 59.24M | 51.92M | 46.60M | 42.51M | 36.10M | 34.40M | 80.80M | 20.90M | 17.70M |
| General & Administrative | 690.34M | 651.03M | 619.97M | 547.70M | 528.79M | 529.90M | 538.70M | 502.03M | 484.75M | 500.71M | 481.97M | 464.27M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 7.00M | 7.00M | 7.00M | 6.00M | 6.00M | 7.00M | 6.00M | 11.00M | 11.00M | 12.00M | 11.00M | 13.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 736.01M | 658.03M | 626.97M | 553.70M | 534.79M | 536.90M | 544.70M | 513.03M | 495.75M | 512.71M | 492.97M | 477.27M | 490.01M | 445.46M | 421.40M | 426.70M | 403.70M | 357.66M | 321.69M | 300.15M | 264.25M | 246.82M | 269.71M | 246.39M | 226.60M | 206.20M | 167.30M | 148.50M | 132.70M |
| Other Expenses | 32.56M | 6.37M | 7.14M | 10.59M | 9.69M | -47.79M | 6.74M | 9.89M | 10.12M | 10.63M | -1.58M | 13.83M | 9.73M | 10.41M | 10.66M | 15.82M | 8.70M | 5.44M | 8.13M | -466.00K | 16.77M | 13.95M | 82.14M | 29.44M | 29.60M | 28.40M | 21.10M | 17.80M | 16.50M |
| Operating Expenses | 943.52M | 840.58M | 802.47M | 705.06M | 687.44M | 688.02M | 684.04M | 648.11M | 624.42M | 631.07M | 603.42M | 587.10M | 592.09M | 540.14M | 509.22M | 524.10M | 493.05M | 440.41M | 396.73M | 364.93M | 340.27M | 312.68M | 398.45M | 318.34M | 292.30M | 269.00M | 269.20M | 187.20M | 166.90M |
| Cost & Expenses | 2.14B | 2.09B | 1.96B | 1.71B | 1.70B | 1.68B | 1.63B | 1.54B | 1.47B | 1.46B | 1.39B | 1.32B | 1.32B | 1.19B | 1.10B | 1.19B | 1.12B | 976.59M | 875.08M | 819.73M | 738.12M | 686.15M | 709.68M | 584.24M | 527.90M | 482.40M | 427.90M | 320.80M | 276.60M |
| Interest Income | 16.62M | 11.02M | 12.22M | 16.27M | 22.06M | 38.81M | 36.08M | 20.69M | 10.71M | 7.02M | 4.39M | 4.21M | 2.62M | 1.86M | 3.04M | 0.00 | 0.00 | 0.00 | 19.26M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 98.86M | 37.78M | 32.72M | 32.80M | 26.63M | 9.83M | 20.76M | 24.23M | 25.53M | 27.17M | 25.66M | 23.87M | 19.35M | 12.07M | 7.95M | 17.56M | 25.69M | 32.19M | 8.59M | 0.00 | 0.00 | 5.51M | 2.10M | 10.64M | 9.00M | 34.90M | 30.10M | 39.20M | 39.20M |
| Depreciation & Amortization | 165.91M | 130.42M | 131.68M | 125.36M | 105.30M | 108.41M | 106.00M | 96.45M | 10.12M | 10.63M | 9.92M | 13.83M | 9.73M | 10.41M | 10.66M | 65.27M | 53.32M | 46.16M | 43.69M | 41.93M | 33.85M | 37.19M | 33.95M | 29.44M | 29.60M | 28.40M | 21.10M | 17.80M | 16.50M |
| EBITDA | 1.00B | 1.01B | 958.43M | 777.97M | 822.09M | 799.64M | 783.97M | 725.01M | 668.23M | 638.31M | 597.04M | 584.53M | 597.61M | 514.35M | 454.91M | 475.98M | 402.20M | 360.78M | 326.84M | 337.67M | 253.94M | 241.01M | 183.48M | 240.26M | 206.10M | 164.80M | 58.70M | 88.10M | 72.90M |
| EBITDA Ratio | 33.86% | 34.18% | 35.03% | 33.28% | 33.66% | 33.06% | 33.95% | 29.42% | 28.66% | 27.35% | 27.61% | 28.90% | 29.08% | 28.01% | 27.04% | 29.30% | 27.30% | 28.44% | 28.76% | 29.19% | 27.93% | 29.75% | 30.91% | 30.22% | 29.26% | 29.30% | 16.15% | 28.79% | 24.53% |
| Operating Income | 817.68M | 873.40M | 821.71M | 645.49M | 708.46M | 739.77M | 661.86M | 624.34M | 567.45M | 517.91M | 517.34M | 511.49M | 528.60M | 449.93M | 394.60M | 389.75M | 348.88M | 295.15M | 283.16M | 284.86M | 219.17M | 196.41M | 149.53M | 210.83M | 176.50M | 136.40M | 37.60M | 70.30M | 56.40M |
| Operating Income Ratio | 27.66% | 29.39% | 29.50% | 27.29% | 29.44% | 30.57% | 28.66% | 28.81% | 27.78% | 26.03% | 27.17% | 27.74% | 28.55% | 27.38% | 26.33% | 24.74% | 23.68% | 23.05% | 24.45% | 25.79% | 22.87% | 22.07% | 17.40% | 26.52% | 25.06% | 22.04% | 8.08% | 17.97% | 16.94% |
| Total Other Income/Expenses | -81.43M | -35.55M | -15.51M | -34.58M | -30.22M | -57.63M | -21.10M | -24.93M | -25.53M | -27.17M | -27.24M | -23.87M | -19.35M | -12.07M | -7.95M | -17.56M | -25.69M | -36.78M | -8.59M | 813.00K | 4.51M | -1.00M | -2.10M | 135.00K | -9.00M | -34.90M | -30.10M | -39.20M | -39.20M |
| Income Before Tax | 736.24M | 837.85M | 806.19M | 610.91M | 678.24M | 682.15M | 641.10M | 600.11M | 541.92M | 490.74M | 490.11M | 487.63M | 509.25M | 437.86M | 386.65M | 372.19M | 323.19M | 262.96M | 274.56M | 285.67M | 223.69M | 195.41M | 147.43M | 210.96M | 167.50M | 101.50M | 7.50M | 31.10M | 17.20M |
| Income Before Tax Ratio | 24.90% | 28.19% | 28.94% | 25.83% | 28.18% | 28.19% | 27.76% | 27.69% | 26.53% | 24.67% | 25.74% | 26.45% | 27.51% | 26.64% | 25.80% | 23.63% | 21.94% | 20.54% | 23.71% | 25.86% | 23.34% | 21.96% | 17.16% | 26.53% | 23.78% | 16.40% | 1.61% | 7.95% | 5.17% |
| Income Tax Expense | 94.01M | 130.09M | 113.35M | 89.34M | 86.04M | 88.35M | 620.79M | 78.61M | 72.87M | 59.12M | 40.10M | 26.18M | 76.28M | 56.10M | 63.34M | 49.71M | 55.12M | 40.76M | 72.59M | 61.62M | 52.80M | 43.19M | 32.88M | 54.85M | 45.20M | 27.10M | 15.80M | 11.20M | 3.10M |
| Net Income | 642.23M | 707.76M | 692.84M | 521.57M | 592.20M | 593.79M | 20.31M | 521.50M | 469.05M | 431.62M | 450.00M | 461.44M | 432.97M | 381.76M | 323.31M | 322.48M | 268.07M | 222.20M | 201.98M | 224.05M | 170.89M | 147.71M | 114.54M | 145.34M | 122.30M | 74.40M | -8.30M | -2.40M | 2.00M |
| Net Income Ratio | 21.72% | 23.81% | 24.87% | 22.05% | 24.61% | 24.54% | 0.88% | 24.06% | 22.97% | 21.70% | 23.63% | 25.03% | 23.39% | 23.23% | 21.57% | 20.47% | 18.20% | 17.36% | 17.44% | 20.28% | 17.83% | 16.60% | 13.33% | 18.28% | 17.36% | 12.02% | -1.78% | -0.61% | 0.60% |
| EPS | 10.87 | 11.80 | 11.25 | 8.40 | 8.76 | 7.71 | 0.25 | 6.46 | 5.70 | 5.12 | 5.27 | 5.25 | 4.77 | 4.13 | 3.37 | 3.25 | 2.67 | 2.16 | 1.77 | 1.87 | 1.39 | 1.13 | 0.88 | 1.14 | 0.99 | 0.61 | -0.07 | -0.02 | 0.01 |
| EPS Diluted | 10.84 | 11.73 | 11.17 | 8.36 | 8.69 | 7.65 | 0.25 | 6.41 | 5.65 | 5.07 | 5.20 | 5.19 | 4.69 | 4.06 | 3.34 | 3.21 | 2.62 | 2.13 | 1.74 | 1.82 | 1.34 | 1.09 | 0.83 | 1.06 | 0.92 | 0.57 | -0.07 | -0.02 | 0.01 |
| Weighted Avg Shares Out | 59.08M | 59.99M | 61.58M | 62.09M | 67.63M | 76.99M | 79.79M | 80.79M | 82.34M | 84.36M | 85.43M | 87.84M | 90.83M | 92.39M | 95.80M | 99.20M | 100.50M | 102.69M | 114.02M | 119.64M | 123.19M | 130.49M | 130.56M | 127.57M | 123.01M | 119.72M | 116.51M | 120.00M | 110.00M |
| Weighted Avg Shares Out (Dil) | 59.27M | 60.33M | 62.03M | 62.41M | 68.17M | 77.62M | 80.60M | 81.42M | 83.09M | 85.15M | 86.55M | 88.98M | 92.33M | 94.06M | 96.86M | 100.56M | 102.51M | 104.24M | 115.95M | 123.07M | 127.58M | 135.76M | 137.51M | 136.74M | 132.63M | 119.72M | 116.51M | 120.00M | 110.00M |
Waters (WAT) Q4 Earnings & Sales Beat Estimates, Fall Y/Y
Waters' (WAT) fourth-quarter results reflect weak end-market momentum. Also, softness in Asia is concerning.
Waters Corporation (WAT) Q4 2023 Earnings Call Transcript
Waters Corporation (WAT) Q4 2023 Earnings Call Transcript
Waters (WAT) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Waters (WAT) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Waters (WAT) Beats Q4 Earnings and Revenue Estimates
Waters (WAT) came out with quarterly earnings of $3.62 per share, beating the Zacks Consensus Estimate of $3.56 per share. This compares to earnings of $3.84 per share a year ago.
Waters Corp beats Q4 sales estimates on strong demand for drug development services
Waters Corp on Tuesday reported fourth-quarter sales ahead of Wall Street estimates, helped by demand for its services used in drug development.
Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2023 Financial Results
Highlights Fourth Quarter 2023 Sales of $819 million declined 4.5% as reported and 8% in organic constant currency, in line with guidance Operational excellence drove gross margin expansion of 170 basis points and adjusted operating margin expansion of 120 basis...
Frothy Waters: 3 Yellow Flags for U.S. Equities Emerge
Noteworthy AI players like Nvidia and Super Micro Computer have witnessed remarkable increases. However, investors should take a prudent approach, emphasizing interpretation over prediction, awareness of FOMO, and strategic management of open positions.
Waters (WAT) to Report Q4 Earnings: What's in the Offing?
Waters' (WAT) fourth-quarter 2023 results are likely to reflect strength in the large molecule market and Waters services business amid weakening demand in China.
What Analyst Projections for Key Metrics Reveal About Waters (WAT) Q4 Earnings
Get a deeper insight into the potential performance of Waters (WAT) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Waters Corporation Schedules Fourth Quarter 2023 Earnings Conference Call
MILFORD, Mass. , Jan. 18, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q4 2023 financial results conference call live on Tuesday, February 6th, 2024 at 8:00 a.m.
Source: https://incomestatements.info
Category: Stock Reports
How did Waters Corporation’s EPS change in 2023?
On a GAAP basis, EPS for fiscal year 2023 was $10.84, compared to $11.73 for fiscal year 2022. On a non-GAAP basis, EPS was $11.75, compared to $12.02 in fiscal year 2022. This includes a headwind of approximately 3% due to unfavorable foreign exchange and a 1% dilution from the Wyatt acquisition.
What were Waters Corporation’s revenue and profits in 2023?
For fiscal year 2023, the Company’s sales were $2,956 million, a decrease of 0.5% as reported, compared to sales of $2,972 million for fiscal year 2022. Currency translation decreased sales by approximately 1%, while the impact of acquisitions increased sales by 2.5%.
How did the Wyatt acquisition affect Waters’ 2023 financials?
In 2023, we completed the largest acquisition in Waters history with Wyatt Technology LLC, which contributed 2.5% to our revenues.